Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
Clinical trial NCT03240016 · COMPLETED
Trial details
- NCT number
- NCT03240016
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2023-06-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.